Videos

The Importance of Median Progression-Free Survival in Oncology Clinical Trials

FEATURING:

Tanios S. Bekaii-Saab, MD; Shubham Pant, MD; Michael Pishvaian, MD, PhD

October 18, 2024

Interview with the Innovators

Watch Video

Median Overall Survival of First-Line Treatments for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

FEATURING:

Tanios S. Bekaii-Saab, MD; Shubham Pant, MD; Michael Pishvaian, MD, PhD

October 11, 2024

Interview with the Innovators

Watch Video

Evaluation of Patients for Pancreatic Cancer

FEATURING:

Tanios S. Bekaii-Saab, MD; Shubham Pant, MD; Michael Pishvaian, MD, PhD

October 7, 2024

Interview with the Innovators

Watch Video

Managing Cost and Patient Risk for Optimal Value-Bases Care

November 13, 2023

Webinars

Watch Video

Bringing Stakeholders Together Bringing Stakeholders Together

September 28, 2023

Watch Video

Why AVBCC?

March 22, 2023

Watch Video

Navigating Care Programs in the Post-OCM era

March 7, 2023

Webinars

Watch Video

Tackling Health Equity in Oncology

December 14, 2022

Webinars

Watch Video

$Relapsed or Refractory FL: Best Practices for Active Surveillance & Reinforcement of Management Plans$

Relapsed or Refractory FL: Best Practices for Active Surveillance & Reinforcement of Management Plans

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

October 4, 2022

Interview with the Innovators

Watch Video

Predicting High-Risk Disease Using Progression of Disease in 24 Months (POD24) and the Key Role of Repeat Biopsy to Exclude the Diagnosis of Transformation to a High-Grade Lymphoma in Patients with Relapsed Follicular Lymphoma

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

September 23, 2022

Interview with the Innovators

Watch Video

Broadening the Variety of Candidate Therapies for R/R Follicular Lymphoma Allows Optimal Personalized Rx Choice, While Patient-Directed Education Helps Attain Greatest Clinical Benefit

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

September 19, 2022

Interview with the Innovators

Watch Video

$Criteria Used to Guide Treatment Decisions and Choice of Therapeutic Agents in Patients with Relapsed or Refractory Follicular Lymphoma$

Criteria Used to Guide Treatment Decisions and Choice of Therapeutic Agents in Patients with Relapsed or Refractory Follicular Lymphoma

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

September 12, 2022

Interview with the Innovators

Watch Video

Specific Dysregulation of B-Cell Signaling in Follicular Lymphoma and Its Role in the Initiation and Progression of This Malignancy

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

September 6, 2022

Interview with the Innovators

Watch Video

Spectrum of Symptoms in Patients Newly Diagnosed with Follicular Lymphoma and the Role of Optimal Coordination of Care at Initial Presentation

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

August 31, 2022

Interview with the Innovators

Watch Video

Epidemiology and expected survivorship in follicular lymphoma and lack of reliable long-term outcome predictors at disease presentation

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

August 23, 2022

Interview with the Innovators

Watch Video

Top Trending Articles

Stay In The Know

Videos

Page 2 of 14

Top Trending Articles

Stay In The Know